A mouse model for cyclin E-dependent genetic instability and tumorigenesis.

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Cyclin E is a key regulator of cell cycle progression.
• Ubiquitination controls protein stability, including cell cycle regulators.
• Phosphorylation events often dictate protein ubiquitination and degradation pathways.

Purpose of the Study:

• To investigate the role of threonine 393 phosphorylation in murine cyclin E ubiquitination.
• To determine the in vivo consequences of a non-phosphorylatable cyclin E T393A mutation.
• To assess the interplay between cyclin E stability and the p53 tumor suppressor pathway in tumorigenesis.

Main Methods:

• Generation of cyclin E(T393A) knockin mice.
• Analysis of cyclin E stability, cell cycle progression, and genetic integrity in wild-type and mutant cells/mice.
• Assessment of tumorigenesis in cyclin E(T393A) mice with concurrent p53 pathway loss.
• In vitro transformation assays using Ras-transformed cells.

Main Results:

• Cyclin E phosphorylation at threonine 393 triggers its ubiquitination and degradation.
• Cyclin E(T393A) knockin mice show increased cyclin E stability but no overt abnormalities.
• Loss of the p53 pathway significantly exacerbates the effects of the T393A mutation, leading to abnormal cell cycle progression and genetic instability (chromosome breaks, translocations).
• The cyclin E(T393A) mutation synergizes with p53 deficiency to accelerate tumor development and increases susceptibility to Ras-induced lung cancer.

Conclusions:

• Threonine 393 phosphorylation is a critical regulatory site for cyclin E ubiquitination and stability.
• The p53 pathway acts as a crucial safeguard against the oncogenic potential of stabilized cyclin E.
• Dysregulation of cyclin E stability, particularly in the context of p53 loss, contributes significantly to genetic instability and tumorigenesis.